InvestorsHub Logo

pumper_stumper

05/04/22 1:06 PM

#149309 RE: Dyno89 #149307

Well which is it? Is Samsung a charity and doing production for ENZC for free, or is ENZC paying? It has to be one or the other!

Well at least we have established that they have zero revenue in the past 3 years, so that one is no longer debated!

https://www.otcmarkets.com/otcapi/company/financial-report/268122/content
https://www.otcmarkets.com/otcapi/company/financial-report/275843/content
https://www.otcmarkets.com/otcapi/company/financial-report/327932/content

Even more funny in that FDA allowed IPF Immune just about 3 years ago, and yet still no revenue! I guess the tubes are hard to fill? Is Onelavi helping with that? The lady that runs that website should be able to help ENZC!

Any word on the audit? Is it still that they meet their audit goal if the audit is completed in 2024, or 2025, or 2026? (days and weeks). I'm sure it's someone else's fault that they aren't audited, right? This is the pink sheets, so that goes with the territory!

foxi

05/04/22 1:32 PM

#149316 RE: Dyno89 #149307

You're right that we have no partnership financing details. Can't say the claims ENZC is paying Samsung are true, nor false, from the info we have today.

It doesn't particularly matter either, imo, since having Samsung be the CDMO is about as ideal a partnership for successfully producing these mAbs as we could wish for. ENZC needs the mAbs for trials which is part of the path to future revenue, so it's great to see them taking this step with Samsung, whoever's paying for it.